Flow Traders U.S.’s Tema Oncology ETF CANC Stock Holding History

Flow Traders U.S.’s Portfolio CANC Stock Details CANC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,384	Closed	-$785K	–	1032
2026 Q1	$785K	Buy	+21,384	New	+$778K	0.02%	517
2025 Q4	–	Sell	-21,939	Closed	-$630K	–	935
2025 Q3	$630K	Buy	+21,939	New	+$583K	0.03%	550

Other funds holding CANC

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

PIA

Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return

OIM

Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WWM

WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Flow Traders U.S.'s CANC Position: Q2 2026 in Review

Flow Traders U.S. sold out of Tema Oncology ETF (CANC) in Q2 2026, closing a stake of 21,384 shares — an estimated $785K sold.

Flow Traders U.S. first reported a position in CANC in Q3 2025 and held it in 2 quarters. The position peaked at $785K in Q1 2026. 14 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

Flow Traders U.S. reported no remaining Tema Oncology ETF position as of Q2 2026 after selling out during the quarter.
Flow Traders U.S. sold 21,384 Tema Oncology ETF shares in Q2 2026, an estimated $785K.
Flow Traders U.S. first reported a position in Tema Oncology ETF in Q3 2025 and held it in 2 quarters.
Flow Traders U.S.'s Tema Oncology ETF position peaked at $785K in Q1 2026.
14 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.